HumeCare states that no wellness metric from the Pod should be relied on alone for medical diagnosis, treatment, or dosing decisions - if a provider wants medical-grade confirmation of something the Pod suggests, HumeCare states they may order a separate diagnostic test
however, if SGLT2is are not tolerated or are contraindicated, or if eGFR is less than adequate, a GLP-1RA with proven CV benefit can be added ( In recent guidelines on diabetes, prediabetes, and CVD from the European Society of Cardiology, in collaboration with the EASD, GLP-1RAs with proven CV benefit (liraglutide, semaglutide, and dulaglutide) are recommended as an add-on therapy to metformin ( Mechanisms for the Cardiovascular Benefits of GLP-1RAS Different mechanisms have been proposed to explain the CV benefits elicited by some GLP-1RAs ( 1c , body weight, and systolic blood pressure were also those associated with CV-event reduction
I find it to be a pretty compelling argument for safety of these meds
This helps prevent sudden spikes or drops in blood sugar, which could interfere with your medications effectiveness
10.3390/antiox9070624 Antioxidants